65899-73-2 | 1-{2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

Packsize	Purity	Availability	Price	Discounted Price
200mg	98%	in stock	$14.00	$10.00
1g	98%	in stock	$26.00	$18.00
5g	98%	in stock	$82.00	$57.00
25g	98%	in stock	$299.00	$209.00
100g	98%	in stock	$946.00	$662.00

Description

• Catalog Number: AI54562
• Chemical Name: 1-{2-[(2-chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole
• CAS Number: 65899-73-2
• Molecular Formula: C16H13Cl3N2OS
• Molecular Weight: 387.7112
• MDL Number: MFCD00057276
• SMILES: Clc1ccc(c(c1)Cl)C(Cn1ccnc1)OCc1ccsc1Cl
• NSC Number: 759169

Computed Properties

• Complexity: 379
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 23
• Hydrogen Bond Acceptor Count: 3
• Rotatable Bond Count: 6
• Undefined Atom Stereocenter Count: 1
• XLogP3: 5.3

Literature

• In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20120701

• In vivo patterns of resistance to the HIV attachment inhibitor BMS-488043.

  Antimicrobial agents and chemotherapy 20110201

• Investigation into UDP-glucuronosyltransferase (UGT) enzyme kinetics of imidazole- and triazole-containing antifungal drugs in human liver microsomes and recombinant UGT enzymes.

  Drug metabolism and disposition: the biological fate of chemicals 20100601

• [Evaluation of susceptibility to antifungal agents of fungal strains isolated from pregnant women with diabetes and healthy pregnant women].

  Ginekologia polska 20090401

• Molecular properties of oxyconazole and tioconazole as the criteria for their bioavailability estimation.

  Acta poloniae pharmaceutica 20080101

• Molecular properties relevant to bioavailability of tioconazole and its derivatives.

  Acta poloniae pharmaceutica 20080101

• Superficial cutaneous Trichosporon asahii infection in an immunocompetent host.

  International journal of dermatology 20061201

• Onychoprotothecosis: report of the first case in Brazil.

  International journal of dermatology 20060901

• Athlete's foot.

  Clinical evidence 20051201

• Treatment costs of three nail lacquers used in onychomycosis.

  The Journal of dermatological treatment 20050101

• In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.

  Chemotherapy 20041201

• Athlete's foot.

  Clinical evidence 20041201

• Difference in percutaneous absorption and intracutaneous distribution in guinea pigs among topical antifungal drugs (tioconazole solution, tioconazole cream, miconazole nitrate solution and bifonazole solution).

  Biological & pharmaceutical bulletin 20040901

• [A case of dystrophic fingernail].

  Enfermedades infecciosas y microbiologia clinica 20040501

• A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.

  International journal of tissue reactions 20040101

• Solubility of drugs in aqueous solutions. Part 3: multicomponent mixed solvent.

  International journal of pharmaceutics 20031128

• Increase of activity of tioconazole against resistant microorganisms by the addition of butylated hydroxyanisole.

  International journal of antimicrobial agents 20031001

• Ciclopiroxolamine: in vitro antifungal activity against clinical yeast isolates.

  International journal of antimicrobial agents 20021101

• Effect of sub-MICs of antimycotics on expression of intracellular esterase of Trichophyton rubrum.

  Medical mycology 20010201

• Synthesis and antifungal activity of novel pyrano[2',3':4,5]thiazolo[2,3-b]quinazolines, pyrido[2',3':4,5]thiazolo[2,3-b]quinazolines and pyrazolo[2',3':4,5]thiazolo[2,3-b]quinazolines.

  Farmaco (Societa chimica italiana : 1989) 20000401

• Current and emerging azole antifungal agents.

  Clinical microbiology reviews 19990101

• Antifungal activity of tioconazole (UK-20,349), a new imidazole derivative.

  Antimicrobial agents and chemotherapy 19790401